SRC and pancreatic neoplasm: Overexpression of CD318 (CDCP1) uniformly correlates with poor overall survival in lung, colon, ovarian, breast, renal, hepatocellular, acute myeloid leukemia and pancreatic cancers, partly due to its involvement in tumor metastasis formation via Src.